Global DNA & RNA Oligonucleotides Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global DNA & RNA Oligonucleotides Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 DNA Oligonucleotides
  • 1.2.3 RNA Oligonucleotides
• 1.3 Market by Application
  • 1.3.1 Global DNA & RNA Oligonucleotides Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospitals and Clinics
  • 1.3.3 Biopharma Companies
  • 1.3.4 Academic & Research Organizations
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global DNA & RNA Oligonucleotides Market Perspective (2016-2027)
• 2.2 DNA & RNA Oligonucleotides Growth Trends by Regions
  • 2.2.1 DNA & RNA Oligonucleotides Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 DNA & RNA Oligonucleotides Historic Market Share by Regions (2016-2021)
  • 2.2.3 DNA & RNA Oligonucleotides Forecasted Market Size by Regions (2022-2027)
• 2.3 DNA & RNA Oligonucleotides Industry Dynamic
  • 2.3.1 DNA & RNA Oligonucleotides Market Trends
  • 2.3.2 DNA & RNA Oligonucleotides Market Drivers
  • 2.3.3 DNA & RNA Oligonucleotides Market Challenges
  • 2.3.4 DNA & RNA Oligonucleotides Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top DNA & RNA Oligonucleotides Players by Revenue
  • 3.1.1 Global Top DNA & RNA Oligonucleotides Players by Revenue (2016-2021)
  • 3.1.2 Global DNA & RNA Oligonucleotides Revenue Market Share by Players (2016-2021)
• 3.2 Global DNA & RNA Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by DNA & RNA Oligonucleotides Revenue
• 3.4 Global DNA & RNA Oligonucleotides Market Concentration Ratio
  • 3.4.1 Global DNA & RNA Oligonucleotides Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by DNA & RNA Oligonucleotides Revenue in 2020
• 3.5 DNA & RNA Oligonucleotides Key Players Head office and Area Served
• 3.6 Key Players DNA & RNA Oligonucleotides Product Solution and Service
• 3.7 Date of Enter into DNA & RNA Oligonucleotides Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 DNA & RNA Oligonucleotides Breakdown Data by Type

• 4.1 Global DNA & RNA Oligonucleotides Historic Market Size by Type (2016-2021)
• 4.2 Global DNA & RNA Oligonucleotides Forecasted Market Size by Type (2022-2027)

5 DNA & RNA Oligonucleotides Breakdown Data by Application

• 5.1 Global DNA & RNA Oligonucleotides Historic Market Size by Application (2016-2021)
• 5.2 Global DNA & RNA Oligonucleotides Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America DNA & RNA Oligonucleotides Market Size (2016-2027)
• 6.2 North America DNA & RNA Oligonucleotides Market Size by Type
  • 6.2.1 North America DNA & RNA Oligonucleotides Market Size by Type (2016-2021)
  • 6.2.2 North America DNA & RNA Oligonucleotides Market Size by Type (2022-2027)
  • 6.2.3 North America DNA & RNA Oligonucleotides Market Size by Type (2016-2027)
• 6.3 North America DNA & RNA Oligonucleotides Market Size by Application
  • 6.3.1 North America DNA & RNA Oligonucleotides Market Size by Application (2016-2021)
  • 6.3.2 North America DNA & RNA Oligonucleotides Market Size by Application (2022-2027)
  • 6.3.3 North America DNA & RNA Oligonucleotides Market Size by Application (2016-2027)
• 6.4 North America DNA & RNA Oligonucleotides Market Size by Country
  • 6.4.1 North America DNA & RNA Oligonucleotides Market Size by Country (2016-2021)
  • 6.4.2 North America DNA & RNA Oligonucleotides Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe DNA & RNA Oligonucleotides Market Size (2016-2027)
• 7.2 Europe DNA & RNA Oligonucleotides Market Size by Type
  • 7.2.1 Europe DNA & RNA Oligonucleotides Market Size by Type (2016-2021)
  • 7.2.2 Europe DNA & RNA Oligonucleotides Market Size by Type (2022-2027)
  • 7.2.3 Europe DNA & RNA Oligonucleotides Market Size by Type (2016-2027)
• 7.3 Europe DNA & RNA Oligonucleotides Market Size by Application
  • 7.3.1 Europe DNA & RNA Oligonucleotides Market Size by Application (2016-2021)
  • 7.3.2 Europe DNA & RNA Oligonucleotides Market Size by Application (2022-2027)
  • 7.3.3 Europe DNA & RNA Oligonucleotides Market Size by Application (2016-2027)
• 7.4 Europe DNA & RNA Oligonucleotides Market Size by Country
  • 7.4.1 Europe DNA & RNA Oligonucleotides Market Size by Country (2016-2021)
  • 7.4.2 Europe DNA & RNA Oligonucleotides Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific DNA & RNA Oligonucleotides Market Size (2016-2027)
• 8.2 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Type
  • 8.2.1 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Type (2016-2027)
• 8.3 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Application
  • 8.3.1 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Application (2016-2027)
• 8.4 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region
  • 8.4.1 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America DNA & RNA Oligonucleotides Market Size (2016-2027)
• 9.2 Latin America DNA & RNA Oligonucleotides Market Size by Type
  • 9.2.1 Latin America DNA & RNA Oligonucleotides Market Size by Type (2016-2021)
  • 9.2.2 Latin America DNA & RNA Oligonucleotides Market Size by Type (2022-2027)
  • 9.2.3 Latin America DNA & RNA Oligonucleotides Market Size by Type (2016-2027)
• 9.3 Latin America DNA & RNA Oligonucleotides Market Size by Application
  • 9.3.1 Latin America DNA & RNA Oligonucleotides Market Size by Application (2016-2021)
  • 9.3.2 Latin America DNA & RNA Oligonucleotides Market Size by Application (2022-2027)
  • 9.3.3 Latin America DNA & RNA Oligonucleotides Market Size by Application (2016-2027)
• 9.4 Latin America DNA & RNA Oligonucleotides Market Size by Country
  • 9.4.1 Latin America DNA & RNA Oligonucleotides Market Size by Country (2016-2021)
  • 9.4.2 Latin America DNA & RNA Oligonucleotides Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa DNA & RNA Oligonucleotides Market Size (2016-2027)
• 10.2 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Type
  • 10.2.1 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Type (2016-2027)
• 10.3 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Application
  • 10.3.1 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Application (2016-2027)
• 10.4 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country
  • 10.4.1 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Eurofins Scientific
  • 11.1.1 Eurofins Scientific Company Details
  • 11.1.2 Eurofins Scientific Business Overview
  • 11.1.3 Eurofins Scientific DNA & RNA Oligonucleotides Introduction
  • 11.1.4 Eurofins Scientific Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
  • 11.1.5 Eurofins Scientific Recent Development
• 11.2 Natera
  • 11.2.1 Natera Company Details
  • 11.2.2 Natera Business Overview
  • 11.2.3 Natera DNA & RNA Oligonucleotides Introduction
  • 11.2.4 Natera Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
  • 11.2.5 Natera Recent Development
• 11.3 BGI
  • 11.3.1 BGI Company Details
  • 11.3.2 BGI Business Overview
  • 11.3.3 BGI DNA & RNA Oligonucleotides Introduction
  • 11.3.4 BGI Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
  • 11.3.5 BGI Recent Development
• 11.4 Illumina
  • 11.4.1 Illumina Company Details
  • 11.4.2 Illumina Business Overview
  • 11.4.3 Illumina DNA & RNA Oligonucleotides Introduction
  • 11.4.4 Illumina Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
  • 11.4.5 Illumina Recent Development
• 11.5 Roche
  • 11.5.1 Roche Company Details
  • 11.5.2 Roche Business Overview
  • 11.5.3 Roche DNA & RNA Oligonucleotides Introduction
  • 11.5.4 Roche Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
  • 11.5.5 Roche Recent Development
• 11.6 LabCorp
  • 11.6.1 LabCorp Company Details
  • 11.6.2 LabCorp Business Overview
  • 11.6.3 LabCorp DNA & RNA Oligonucleotides Introduction
  • 11.6.4 LabCorp Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
  • 11.6.5 LabCorp Recent Development
• 11.7 Berry Genomics
  • 11.7.1 Berry Genomics Company Details
  • 11.7.2 Berry Genomics Business Overview
  • 11.7.3 Berry Genomics DNA & RNA Oligonucleotides Introduction
  • 11.7.4 Berry Genomics Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
  • 11.7.5 Berry Genomics Recent Development
• 11.8 Brooks Life Sciences
  • 11.8.1 Brooks Life Sciences Company Details
  • 11.8.2 Brooks Life Sciences Business Overview
  • 11.8.3 Brooks Life Sciences DNA & RNA Oligonucleotides Introduction
  • 11.8.4 Brooks Life Sciences Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
  • 11.8.5 Brooks Life Sciences Recent Development
• 11.9 Macrogen
  • 11.9.1 Macrogen Company Details
  • 11.9.2 Macrogen Business Overview
  • 11.9.3 Macrogen DNA & RNA Oligonucleotides Introduction
  • 11.9.4 Macrogen Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
  • 11.9.5 Macrogen Recent Development
• 11.10 Genotypic Technology
  • 11.10.1 Genotypic Technology Company Details
  • 11.10.2 Genotypic Technology Business Overview
  • 11.10.3 Genotypic Technology DNA & RNA Oligonucleotides Introduction
  • 11.10.4 Genotypic Technology Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
  • 11.10.5 Genotypic Technology Recent Development
• 11.11 Dna Link
  • 11.11.1 Dna Link Company Details
  • 11.11.2 Dna Link Business Overview
  • 11.11.3 Dna Link DNA & RNA Oligonucleotides Introduction
  • 11.11.4 Dna Link Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
  • 11.11.5 Dna Link Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer